Posters presented at the CHEST 2024 annual meeting demonstrated air pollution's role in lung impairment and disease, highlighting the urgent need for providers to address the escalating impacts of ...
MORRISVILLE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, ...
Liquidia to feature two live posters sessions and five encore presentations covering its investigational products, YUTREPIA™ (treprostinil) inhalation powder and L606 (liposomal treprostinil) ...
Please provide your email address to receive an email when new articles are posted on . Full pulmonary function tests contribute useful diagnostic information for evaluating patients with ...
In a recent study posted to the bioRxiv* preprint server, researchers examined patients with pulmonary post-acute sequelae (PASC) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback